CIK: 0001634557
申报总市值
—
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | REYN | Reynolds Consumer Products Inc. | 股票-其他 | 41.94% | — | +127.21% | |
| 2 | ALKS | Alkermes plc | 股票-医疗保健 | 17.64% | — | +8.96% | |
| 3 | ABBV | Abbvie INC | 股票-医疗保健 | 16.58% | — | — | |
| 4 | PRTA | Prothena Corporation plc | 股票-其他 | 16.24% | — | +12.21% | |
| 5 | NWBO | Northwest Biotherapeutics | 股票-其他 | 7.38% | — | +22.37% | |
| 6 | TBPH | Theravance Biopharma, Inc. | 股票-其他 | 0.23% | -71.30% | EXIT |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | REYN | Reynolds Consumer Products Inc. | +0.6% | +127.21% | 加仓 |
| 2 | NWBO | Northwest Biotherapeutics | -5.4% | +22.37% | 加仓 |
| 3 | ALKS | Alkermes plc | -5.9% | +8.96% | 加仓 |
| 4 | PRTA | Prothena Corporation plc | -6.1% | +12.21% | 加仓 |
| 5 | ABBV | Abbvie INC | — | NEW | 新建仓 |
| 6 | TBPH | Theravance Biopharma, Inc. | — | NEW | 新建仓 |